Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2015 / Cilt: 49 - Sayı: 1

The clinical and dermoscopic features of extremity melanomas

Ekstremite melanomlarının klinik ve dermoskopik özellikleri

Pages
13–17
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Breslow thickness positively correlated with diameter of the lesion, presence of 3 or more colors in lesion, blue-white veil feature and linear white streaks (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Dermoscopy is a noninvasive tool that helps differentiate structures that cannot be seen by naked eye.
📊
Key Findings & Data:Materials and Methods: 40 patients with melanoma of the extremities were included in this study.
💡
Conclusion & Impact:Breslow thickness positively correlated with diameter of the lesion, presence of 3 or more colors in lesion, blue-white veil feature and linear white streaks (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: Dermoscopy is a noninvasive tool that helps differentiate structures that cannot be seen by naked eye. Dermoscopic and clinical features of malignant melanomas of the extremities are not well described in the literature. Therefore, in this study, we aimed to determine the dermoscopic and clinical characteristics of melanoma of the extremities. Materials and Methods: 40 patients with melanoma of the extremities were included in this study. Their dermoscopic and clinical images, histopathological and clinical data were assessed. The relationships between Breslow thickness and dermoscopic characteristics were evaluated. Results: The most frequent localization in women was the lower extremities, whereas it was the upper extremities in men. The most common subtype of melanoma was superficial spreading melanoma of the extremities. The mean age of the males and females was 56.21±15.20 and 53.09±13.96, respectively. The most common dermoscopic feature of extremity melanoma was irregular dots (85%). Breslow thickness positively correlated with diameter of the lesion, presence of 3 or more colors in lesion, blue-white veil feature and linear white streaks (p

Özet

Amaç: Dermoskopi, çıplak gözle görülemeyen yapıların ayırt edilebilmesine yardım eden, invaziv olmayan bir araçtır. Ekstremitelerdeki malign melanomların dermoskopik ve klinik özellikleri literatürde iyi bir şekilde tanımlanmamıştır. Bu yüzden, biz bu çalışmada ekstremitelerdeki melanomların dermoskopik ve klinik özelliklerini tanımlamayı amaçladık. Gereç ve Yöntem: Ekstremitelerinde melanomu olan 40 hasta çalışmaya dahil edildi. Dermoskopik ve klinik görüntüleri, histopatolojik ve klinik bilgileri incelendi. Breslow kalınlığı ve dermoskopik özellikler arasındaki ilişkiler değerlendirildi. Bulgular: Kadınlarda en sık yerleşim yeri alt ekstremiteler olmakla birlikte, erkeklerde en sık yerleşim yeri üst ekstremiteydi. Melanomun ekstremitelerde gözlenen en sık alt tipi yüzeyel yayılımlı malign melanomdu. Ekstremitesinde melanomu olan erkeklerde ortalama yaş 56,21±15,20 iken, ekstremitesinde melanomu olan kadınlarda ortalama yaş 53,09±13,96 idi. Ekstremite melanomlarındaki en sık dermoskopik özellik düzensiz noktalardı (%85). Breslow kalınlığı ile çap arasında, lezyonda 3 veya daha fazla rengin bulunmasıyla, mavi-beyaz peçe yapısıyla ve lineer beyaz çizgilerle arasında pozitif korelasyonlar saptandı (p

🔖

Cite This Article

CENGİZ, F. P., EMİROĞLU, N., HOFMANN, R. W. (2022). The clinical and dermoscopic features of extremity melanomas. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 49 - Sayı: 1, 13–17. https://ajindex.com/articles/621807

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Pehamberger H, Binder M, Steiner A, Wolff K: In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma. J Invest Dermatol 1993;100:356S-62S
  2. Soyer HP, Argenziano G, Chimenti S, Ruocco V: Dermoscopy of pigmented skin lesions. Eur J Dermatol 2001;11:270-6
  3. Binder M, Puespoeck-Schwarz M, Steiner A, et al: Epiluminescence microscopy of small pigmented skin lesions: short-term formal training improves the diagnostic performance of dermatologists. J Am Acad Dermatol 1997;36:197-202
  4. Westerhoff K, McCarthy WH, Menzies SW: Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol 2000;143:1016-20
  5. Stolz W, Braun-Falco O, Bilek P, Landthaler M, Burgdorf WHC, Cognetta AB: Color atlas of dermatoscopy. 2nd ed. Berlin: Blackwell Wissenschafts-Verlag; 2002
  6. Goldman L: Some investigative studies of pigmented nevi with cutaneous microscopy. J Invest Dermatol 1951;16:407-26
  7. Friedman RJ, Rigel DS, Kopf AW: Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin 1985;35:130-51
  8. Soyer HP, Argenziano G, Zalaudek I, et al: Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology 2004;208:27-31
  9. Argenziano G, Fabbrocini G, Carli P, et al: Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 1998;134:1563-70
  10. Lasithiotakis K, Leiter U, Meier F, et al: Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 2008;112:1795-804
  11. Chao C, Martin RC II, Ross MI, et al: Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004;11:259-64
  12. Scoggins CR, Ross MI, Reintgen DS, et al: Gender-related differences in outcome for melanoma patients. Ann Surg 2006;243:693-8, discussion 698-700
  13. Callender GG, Egger ME, Burton AL, et al: Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg 2011;202:659-65
  14. Maldonado JL, Fridlyand J, Patel H, et al: Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95:1878-90
  15. Curtin JA, Fridlyand J, Kageshita T, et al: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353:2135-47
  16. Egger ME, Tabler B